Runtogen is a premier US biotechnology company focused on delivering high-quality cell models and precision CRISPR gene editing services. Our extensive portfolio includes tumor cell lines, primary cells, engineered cell lines, CRISPR gene editing cell lines, and other advanced genome editing solutions tailored for research and drug development. With a foundation in scientific rigor and an unwavering commitment to reliability, we support global partners in academia and industry in accelerating discovery across molecular biology, oncology, and therapeutic innovation. With extensive expertise in cell line development, gene editing, and custom cell-based assays, we provide high-quality solutions tailored to meet the most demanding scientific and therapeutic needs.